fda 503a bulks list peptides bpc-157 panel backs compounded BPC-157, KPV in win for RFK Jr TB-500 FDA 503A Decision: Why

TB 500 FDA 503A Decision: Why It Wasn't Added to the Bulks Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr. MedPage Today

SKU: 20357381964 · From telecamera-cantiere.com